老年痴呆症药物治疗进展_施安国.pdfVIP

338 　　　　　　　　　　　　　　2000 　24　 6 metabolism in drug discovery and development [ J] . p l pharmacol, 1991, 111:1-12. Pharmacol R ev, 1997, 49(7):403-448. [20] Chinje E, Kentish P, Jarnot B, et al.Induction of the [ 16] Prentis RA, Lis , Walker SR.Pharmaceutical innovation C P4A subfamily by perfluorodecanoic acid:the rat and by seven UK-owned pharmaceutical companies (1964- the guinea pig as susceptible and non-susceptible species 1985)[J] .Br J Clin Pharmacol, 1998, 25:387-396. [J] .Toxicol Lett, 1994, 71:69-75. [ 17] Toon S, Rowland M.Structure-pharmacokinetic relation- [21] Tingle MD, Park BK.Metabolism of ciamexon by human ships among the barbiturate in rat[J].J Pharmacol Exp liver microsome:an investigation into the formation of Ther, 1983, 225:752-763. stable chemically reactive and cytotoxic metabolite[J] .Br [ 18] Arrowsmith JE, Campbell SF, Cross PE, et al.Long act- J Clin Pharmacol, 1990, 29:549-556. ing dihydropyridine calcium antagonists:1-2-alkoxymethyl [22] Honig RK, Wortham DC, Zamani K, et al.Terfenadine- derivatives in corporating basic substituents[J] .J M ed ketoconazole interaction:pharmacokinetic and electrocar- Chem, 1986, 29:1696-1702. diographic consequences[J].JAMA, 1993, 269:1535- [ 19] Jensen CB, Jollow DJ.The role of N-hydroxyphenetidine 1539. in phenacetin-induced hemolytic anemia[J].Toxicol Ap- 施安国, 　费艳秋, 　安富荣 (, 200001) 　:, 。 , , 。 :;;; :R971　　　:A　　　:1001-5094(2000)06-0338-04 Development of Drug Therapy f or Alzheimers Disease SHI An-guo, 　FEI an-qiu, 　AN Fu-rong (Clinic Pharmacy Laboratory , Dep artment of Pharmacy , R enj i H op ital, Shanghai Second